HVIVO PLC — AGM Information 2015

May 26, 2015

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2274O

hVIVO plc

26 May 2015

For immediate release 12.00pm: 26 May 2015

HVIVO PLC

("hVIVO" or the "Company")

Result of Annual General Meeting

hVIVO plc (AIM: RVG), the pioneer of human challenge models of disease, is pleased to announce that all resolutions proposed at its Annual General Meeting, held at 10am on 21 May 2015, were duly passed.

For further information please contact:

hVIVO plc                                                                                          +44 207 756 1300

Kym Denny (Chief Executive Officer)

Graham Yeatman (Chief Financial & Business Officer)

Media Enquiries                                                      +44 203 021 3933 / +44 7854 979 420

Colin Paterson (Director of Marketing, Communication and Public Relations)

Numis Securities Limited                                                                      +44 207 260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black / Michael Burke (Corporate Broking)

Notes to Editors:

hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases.  Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGPKADPKBKDOPB